What were the main takeaways from the JPM Morgan Healthcare Conference for the Biotech industry? Rich Leavitt and Doug Bixby, Alliant Life Sciences, discuss the recent conference and main insurance considerations for 2024 including AI, M&A and the recent uptick in off-label use of weight loss drugs by the public.

What were the main takeaways from the JPM Morgan Healthcare Conference for the Biotech industry? Rich Leavitt and Doug Bixby, Alliant Life Sciences, discuss the recent conference and main insurance considerations for 2024 including AI, M&amp;A and the recent uptick in off-label use of weight loss drugs by the public.

Insurance Considerations for Biotech in 2024

The Alliant Insurance podcast is dedicated to Insurance and risk management solutions, and trends shaping the market today. The team of industry specialists explore topics ranging from cyber to workers' comp and everything in between. With the help of expert guests from across the market, each episode is a bite-sized 10-15 minutes covering what business owners and risk managers need to know about their insurance programs.

Share Insurance Considerations for Biotech in 2024

Sign up to save your podcasts

Insurance Considerations for Biotech in 2024

Insurance Considerations for Biotech in 2024

More shows like Alliant Insurance Services

Freakonomics Radio